SIMFO

Curated by Signal

Developer of analytics platform for cancer therapy

Overview

simfo has developed an analytics platform for precision cancer diagnostics and therapy. The platform maintrac is an analysis platform for the early detection of circulating tumor cells to enable identification of therapies through analytics of scientific studies and preclinical phases of drug development and distinguish responders from non-responders.

Key facts

Founded: 2000
Headquarters: Bayreuth, Germany
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Invacare Corporation
Developer of smart power chair for mobility disabled people
Life Sciences TechnologyMinden, Germany
RooWalk
Provider of electric mobility aid for motion-impaired children and adults
Life Sciences TechnologyBerlin, Germany
Dytrex
Develops and markets hometesting diagnostic products
Life Sciences TechnologyBerlin, Germany

About SIMFO

What does SIMFO do?

simfo has developed an analytics platform for precision cancer diagnostics and therapy.

Where is SIMFO headquartered?

SIMFO is headquartered in Bayreuth, Germany.

When was SIMFO founded?

SIMFO was founded in 2000.

Which sector is SIMFO in?

SIMFO operates in Life Sciences Technology.

Who are SIMFO's competitors?

Companies similar to SIMFO include Invacare Corporation, RooWalk, and Dytrex.